Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis

S B Jakowlew1, T W Moody, L You

  • 1Department of Cell and Cancer Biology, Medicine Branch, National Cancer Institute, Rockville, Maryland 20850, USA.

Insights

Decreased expression of transforming growth factor-beta type II receptor (TGF-beta RII) in lung adenomas suggests its role in urethane-induced mouse lung cancer. This loss of TGF-beta RII may drive autonomous cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Carcinogenesis

Background:

  • Transforming growth factor-beta (TGF-beta) inhibits epithelial cell proliferation via TGF-beta receptors (RI and RII).
  • Loss of TGF-beta growth inhibition is implicated in tumor development.
  • Understanding TGF-beta signaling in lung cancer is crucial.

Purpose of the Study:

  • To investigate the roles of TGF-beta1, -beta2, -beta3, TGF-beta RI, and TGF-beta RII in urethane-induced mouse lung tumorigenesis.
  • To analyze the expression patterns of these molecules during lung cancer development.

Main Methods:

  • Immunohistochemical analysis of TGF-beta ligands and receptors in A/J mouse lung tissues.
  • In situ hybridization to detect mRNA expression of TGF-beta RI and RII.
  • Comparison of expression in normal bronchioles versus urethane-induced lung adenomas and derived cell lines.

Main Results:

  • TGF-beta ligands and TGF-beta RI were expressed at comparable levels in normal bronchioles and adenomas.
  • TGF-beta RII protein and mRNA expression were significantly reduced in lung adenomas compared to normal bronchioles.
  • Lower TGF-beta RII mRNA levels were observed in tumorigenic lung cells derived from urethane-induced tumors.

Conclusions:

  • A decrease in TGF-beta RII expression is associated with urethane-induced mouse lung carcinogenesis.
  • Reduced TGF-beta RII may contribute to autonomous cell proliferation in lung tumors.
  • TGF-beta RII downregulation is a potential mechanism in lung cancer development.